Garipalli Vivek
Known title: Chief Executive OfficerCIK: 0001839260
Garipalli Vivek's purchase track record
How the stock did after each of Garipalli Vivek's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since June 17, 2024
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+132.3%
3 months: +83.3%
Beat the S&P 500
67%
median +119.5% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/7/2025 | CLOV | $999K | +18.1% | -7.7% | +7.2% |
| 8/9/2024 | CLOV | $1000K | +83.3% | +132.3% | +12.8% |
| 6/17/2024 | CLOV | $1.00M | +166.1% | +171.3% | +11.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CLOV | ▲ Buy | Option Exercise | 1,655,949 | $0 | 1/7/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 1,655,949 | $4.3M | 1/7/2026 | View on chart |
| CLOV | ▲ Buy | Open Market | 31,980 | $69K | 8/8/2025 | View on chart |
| CLOV | ▲ Buy | Open Market | 415,000 | $930K | 8/7/2025 | View on chart |
| CLOV | ▲ Buy | Option Exercise | 1,670,965 | $0 | 1/7/2025 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 1,670,965 | $6.0M | 1/7/2025 | View on chart |
| CLOV | ▲ Buy | Open Market | 531,700 | $1000K | 8/9/2024 | View on chart |
| CLOV | ▲ Buy | Open Market | 877,567 | $1.0M | 6/17/2024 | View on chart |
| CLOV | ▲ Buy | Option Exercise | 1,561,065 | — | 1/7/2024 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 1,561,065 | $1.5M | 1/7/2024 | View on chart |
| CLOV | ▲ Buy | Option Exercise | 1,569,594 | — | 1/7/2023 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 1,569,594 | $1.6M | 1/7/2023 | View on chart |
| CLOV | ▲ Buy | Option Exercise | 3,342,698 | — | 1/7/2022 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 1,664,825 | $5.3M | 1/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.